214 results on '"Segnani, Cristina"'
Search Results
2. Prokineticin‐2 Is Highly Expressed in Colonic Mucosa of Early Parkinson's Disease Patients.
3. Enteric Glia and Brain Astroglia: Complex Communication in Health and Disease along the Gut-Brain Axis.
4. Pathological remodelling of colonic wall following dopaminergic nigrostriatal neurodegeneration
5. Interplay between colonic inflammation and tachykininergic pathways in the onset of colonic dysmotility in a mouse model of diet-induced obesity
6. Dietary supplementation with the probiotic SF68 reinforces intestinal epithelial barrier in obese mice by improving butyrate bioavailability
7. Enteric Glia and Brain Astroglia: Complex Communication in Health and Disease along the Gut-Brain Axis
8. Intestinal histomorphological and molecular alterations in patients with Parkinson's disease.
9. Colonic motor dysfunctions in a mouse model of high-fat diet-induced obesity: an involvement of A2B adenosine receptors
10. Role of cyclooxygenase pathways in bowel fibrotic remodelling in a murine model of experimental colitis
11. Intestinal histomorphological and molecular alterations in patients with Parkinson's disease
12. Aging Modulates the Influence of Arginase on Endothelial Dysfunction in Obesity
13. Different Impact of Essential Hypertension on Structural and Functional Age-Related Vascular Changes
14. 732 EFFECTS OF PROBIOTIC MIXTURE STANDARDIZED WITH MALTODEXTRIN ON COLONIC DYSMOTILITY AND ENTERIC INFLAMMATION IN A SPONTANEOUS MODEL OF ACCELERATE SENESCENCE
15. Role of cyclooxygenase pathways in bowel fibrotic remodelling in a murine model of experimental colitis.
16. From the intestinal mucosal barrier to the enteric neuromuscular compartment: an integrated overview on the morphological changes in Parkinson’s disease
17. An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis
18. Quantitative evaluation of myenteric ganglion cells in normal human left colon: implications for histopathological analysis
19. NLRP3 at the crossroads between immune/inflammatory responses and enteric neuroplastic remodelling in a mouse model of diet‐induced obesity
20. Tu1873 ORAL SUPPLEMENTATION WITH THE PROBIOTIC SF68® IMPROVES THE INTESTINAL EPITHELIAL BARRIER IN OBESE MICE BY ENHANCING BUTYRATE BIOAVAILABILITY
21. 26 LACTIPLANTIBACILLUS PLANTARUM HEAL9 AS A SUITABLE APPROACH TARGETING MICROBIOTA GUT-BRAIN AXIS FOR THE ALLEVIATION OF ALZHEIMER'S DISEASE AND RELATED BOWEL SYMPTOMS
22. Rosuvastatin prevents angiotensin II-induced vascular changes by inhibition of NAD(P)H oxidase and COX-1
23. Immunohistochemical analysis of myenteric ganglia and interstitial cells of Cajal in ulcerative colitis
24. Deepening the Mechanisms of Visceral Pain Persistence: An Evaluation of the Gut-Spinal Cord Relationship
25. Prodromal Intestinal Events in Alzheimer’s Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition
26. Colonic dysmotility and inflammation associated with high fat diet-induced obesity: role of the enteric glia
27. Thyroid dysfunction in megalin deficient mice
28. EXPRESSION OFTGF-beta1, FIBRONECTIN AND RhoA IN IgA NEPHROPATHY
29. Cellular and subcellular localization of the small G protein RhoA in the human and rat embryonic and adult kidney
30. The hunt for peripheral chemoreceptors in an unusual species
31. Su1632 – Parkinson’s Disease Patients with Constipation: Results of a Histomorphological and Molecular Pilot Study
32. Histomorphological analysis of the colonic barrier in a mouse model of obesity
33. Colonic wall remodeling in patients with short- and long-lasting ulcerative colitis
34. Transmural remodelling of colonic wall following dopaminergic nigrostriatal neurodegeneration
35. Histopathological rearrangements of the colonic wall following dopaminergic nigrostriatal neurodegeneration
36. Interplay between colonic inflammation and tachykininergic pathways in the onset of colonic dysmotility in a mouse model of diet-induced obesity
37. The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity
38. Colonic Dysmotility Associated with High Fat Diet-Induced Obesity: Role of the Enteric Glia
39. Effects of L-DOPA/Benserazide Co-Treatment on Colonic Dysmotility and Enteric Inflammation Following Dopaminergic Nigrostriatal Neurodegeneration
40. Protective Role of Flavonoids Against Colonic Motor Dysfunctions Associated with High Fat Diet-Induced Obesity
41. Muscle and vascular remodelling in inflamed, fibrotic colon of patients with ulcerative colitis
42. Alterations of Colonic Neuromuscular Excitatory Cholinergic Pathway in a Rat Model of 6-Hydroxydopamine-Induced Parkinson's Disease
43. Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration
44. Sa1694 Colonic Inflammation in Experimental Parkinson's Disease: Evidence of Altered Colonic Tachykininergic Neurotransmissio
45. Fibrotic and Vascular Remodelling of Colonic Wall in Patients with Active Ulcerative Colitis
46. Deranged expression of smooth muscle molecules in colonic tunica muscularis of DD patients
47. Tissue remodelling in the colonic wall of patients with ulcerative colitis
48. Pathological Remodeling of the Gut Barrier as a Prodromal Event of High-Fat Diet-Induced Obesity.
49. Gastrointestinal neuromuscular disease: methodological and ontological issues in histopathological analysis
50. Cx43, RhoA and c-kit in diverticular disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.